Association of metabolic syndrome and human papillomavirus infection in men and women residing in the United States

Jennifer C. Molokwu, Eribeth Penaranda, David Lopez, Alok Dwivedi, Christopher Dodoo, Navkiran Shokar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: An estimated 33% of adults in the United States have metabolic syndrome (MetS), which has been associated with an increased risk for various cancer types. Theories of synergism among components of MetS that increase cancer risk via chronic inflammation and oxidative stress have been proposed. We hypothesize that men and women with MetS may have compromised immunological response resulting in increased risk for persistent human papillomavirus (HPV) infection. The goal of this study is to determine the association of MetS with HPV types 6, 11, 16, and 18 and to explore variation of these associations by gender using data from a national survey. Methods: We conducted a retrospective cross-sectional study using data from the National Health and Nutrition Examination Survey. Results: Thirty-two percent of the population sampled met the criteria for MetS (16% men and 33% women). Nineteen percent tested positive for HPV (6, 11, 16, and 18). Prevalence of HPV infection was estimated at 13% for men and 30% for females. MetS was found to be significantly associated with increased risk of HPV6, 11, 16, or 18 in the entire cohort [RR = 1.24; 95% confidence interval (CI), 1.03-1.48] and in females (RR = 1.26; 95% CI, 1.02-1.56). Although the adjusted risk of HPV+ve status was found to be 21%higher inmen with MetS compared with those without, this difference did not attain statistical significance. Conclusions: We observed a significant association between metabolic syndrome and HPV sero-positivity among the overall population and among females. Although not significant, a similar effect was noted in men. Further prospective studies are needed to better understand this relationship. Impact: To the best of our knowledge, this is the first study evaluating the impact of metabolic syndrome on HPV positivity in both males and females. Cancer Epidemiol Biomarkers Prev; 26(8); 1321-7.

Original languageEnglish (US)
Pages (from-to)1321-1327
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume26
Issue number8
DOIs
StatePublished - Aug 1 2017
Externally publishedYes

Fingerprint

Papillomavirus Infections
Human papillomavirus 11
Human papillomavirus 6
Confidence Intervals
Nutrition Surveys
Tumor Biomarkers
Population
Neoplasms
Oxidative Stress
Cross-Sectional Studies
Prospective Studies
Inflammation

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Association of metabolic syndrome and human papillomavirus infection in men and women residing in the United States. / Molokwu, Jennifer C.; Penaranda, Eribeth; Lopez, David; Dwivedi, Alok; Dodoo, Christopher; Shokar, Navkiran.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 26, No. 8, 01.08.2017, p. 1321-1327.

Research output: Contribution to journalArticle

Molokwu, Jennifer C. ; Penaranda, Eribeth ; Lopez, David ; Dwivedi, Alok ; Dodoo, Christopher ; Shokar, Navkiran. / Association of metabolic syndrome and human papillomavirus infection in men and women residing in the United States. In: Cancer Epidemiology Biomarkers and Prevention. 2017 ; Vol. 26, No. 8. pp. 1321-1327.
@article{11a8ef98f5c1477398f2e401cd9bef0d,
title = "Association of metabolic syndrome and human papillomavirus infection in men and women residing in the United States",
abstract = "Background: An estimated 33{\%} of adults in the United States have metabolic syndrome (MetS), which has been associated with an increased risk for various cancer types. Theories of synergism among components of MetS that increase cancer risk via chronic inflammation and oxidative stress have been proposed. We hypothesize that men and women with MetS may have compromised immunological response resulting in increased risk for persistent human papillomavirus (HPV) infection. The goal of this study is to determine the association of MetS with HPV types 6, 11, 16, and 18 and to explore variation of these associations by gender using data from a national survey. Methods: We conducted a retrospective cross-sectional study using data from the National Health and Nutrition Examination Survey. Results: Thirty-two percent of the population sampled met the criteria for MetS (16{\%} men and 33{\%} women). Nineteen percent tested positive for HPV (6, 11, 16, and 18). Prevalence of HPV infection was estimated at 13{\%} for men and 30{\%} for females. MetS was found to be significantly associated with increased risk of HPV6, 11, 16, or 18 in the entire cohort [RR = 1.24; 95{\%} confidence interval (CI), 1.03-1.48] and in females (RR = 1.26; 95{\%} CI, 1.02-1.56). Although the adjusted risk of HPV+ve status was found to be 21{\%}higher inmen with MetS compared with those without, this difference did not attain statistical significance. Conclusions: We observed a significant association between metabolic syndrome and HPV sero-positivity among the overall population and among females. Although not significant, a similar effect was noted in men. Further prospective studies are needed to better understand this relationship. Impact: To the best of our knowledge, this is the first study evaluating the impact of metabolic syndrome on HPV positivity in both males and females. Cancer Epidemiol Biomarkers Prev; 26(8); 1321-7.",
author = "Molokwu, {Jennifer C.} and Eribeth Penaranda and David Lopez and Alok Dwivedi and Christopher Dodoo and Navkiran Shokar",
year = "2017",
month = "8",
day = "1",
doi = "10.1158/1055-9965.EPI-17-0129",
language = "English (US)",
volume = "26",
pages = "1321--1327",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Association of metabolic syndrome and human papillomavirus infection in men and women residing in the United States

AU - Molokwu, Jennifer C.

AU - Penaranda, Eribeth

AU - Lopez, David

AU - Dwivedi, Alok

AU - Dodoo, Christopher

AU - Shokar, Navkiran

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background: An estimated 33% of adults in the United States have metabolic syndrome (MetS), which has been associated with an increased risk for various cancer types. Theories of synergism among components of MetS that increase cancer risk via chronic inflammation and oxidative stress have been proposed. We hypothesize that men and women with MetS may have compromised immunological response resulting in increased risk for persistent human papillomavirus (HPV) infection. The goal of this study is to determine the association of MetS with HPV types 6, 11, 16, and 18 and to explore variation of these associations by gender using data from a national survey. Methods: We conducted a retrospective cross-sectional study using data from the National Health and Nutrition Examination Survey. Results: Thirty-two percent of the population sampled met the criteria for MetS (16% men and 33% women). Nineteen percent tested positive for HPV (6, 11, 16, and 18). Prevalence of HPV infection was estimated at 13% for men and 30% for females. MetS was found to be significantly associated with increased risk of HPV6, 11, 16, or 18 in the entire cohort [RR = 1.24; 95% confidence interval (CI), 1.03-1.48] and in females (RR = 1.26; 95% CI, 1.02-1.56). Although the adjusted risk of HPV+ve status was found to be 21%higher inmen with MetS compared with those without, this difference did not attain statistical significance. Conclusions: We observed a significant association between metabolic syndrome and HPV sero-positivity among the overall population and among females. Although not significant, a similar effect was noted in men. Further prospective studies are needed to better understand this relationship. Impact: To the best of our knowledge, this is the first study evaluating the impact of metabolic syndrome on HPV positivity in both males and females. Cancer Epidemiol Biomarkers Prev; 26(8); 1321-7.

AB - Background: An estimated 33% of adults in the United States have metabolic syndrome (MetS), which has been associated with an increased risk for various cancer types. Theories of synergism among components of MetS that increase cancer risk via chronic inflammation and oxidative stress have been proposed. We hypothesize that men and women with MetS may have compromised immunological response resulting in increased risk for persistent human papillomavirus (HPV) infection. The goal of this study is to determine the association of MetS with HPV types 6, 11, 16, and 18 and to explore variation of these associations by gender using data from a national survey. Methods: We conducted a retrospective cross-sectional study using data from the National Health and Nutrition Examination Survey. Results: Thirty-two percent of the population sampled met the criteria for MetS (16% men and 33% women). Nineteen percent tested positive for HPV (6, 11, 16, and 18). Prevalence of HPV infection was estimated at 13% for men and 30% for females. MetS was found to be significantly associated with increased risk of HPV6, 11, 16, or 18 in the entire cohort [RR = 1.24; 95% confidence interval (CI), 1.03-1.48] and in females (RR = 1.26; 95% CI, 1.02-1.56). Although the adjusted risk of HPV+ve status was found to be 21%higher inmen with MetS compared with those without, this difference did not attain statistical significance. Conclusions: We observed a significant association between metabolic syndrome and HPV sero-positivity among the overall population and among females. Although not significant, a similar effect was noted in men. Further prospective studies are needed to better understand this relationship. Impact: To the best of our knowledge, this is the first study evaluating the impact of metabolic syndrome on HPV positivity in both males and females. Cancer Epidemiol Biomarkers Prev; 26(8); 1321-7.

UR - http://www.scopus.com/inward/record.url?scp=85026831881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026831881&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-17-0129

DO - 10.1158/1055-9965.EPI-17-0129

M3 - Article

VL - 26

SP - 1321

EP - 1327

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 8

ER -